Filter News
Area of Research
- (-) Neutron Science (10)
- (-) Nuclear Science and Technology (24)
- Advanced Manufacturing (1)
- Biology and Environment (5)
- Clean Energy (32)
- Climate and Environmental Systems (2)
- Computer Science (2)
- Energy Sciences (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (4)
- Isotopes (3)
- Materials (45)
- Materials for Computing (4)
- National Security (5)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (3)
- Supercomputing (17)
News Topics
- (-) Climate Change (1)
- (-) Isotopes (5)
- (-) Materials Science (10)
- (-) Nuclear Energy (22)
- (-) Quantum Science (3)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (8)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (5)
- Biomedical (8)
- Composites (1)
- Computer Science (8)
- Coronavirus (6)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (2)
- Fusion (6)
- Machine Learning (1)
- Mathematics (1)
- Microscopy (1)
- Molten Salt (4)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (30)
- Physics (4)
- Polymers (1)
- Security (1)
- Summit (5)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.